Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

SELECTA BIOSCIENCES INC (SELB) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/18/2022 8-K Investor presentation
Docs: "2022 PLACEHOLDER FOR SPLASH PAGE"
08/04/2022 8-K Investor presentation
Docs: "2022 PLACEHOLDER FOR SPLASH PAGE"
04/13/2022 8-K Investor presentation
Docs: "2022 PLACEHOLDER FOR SPLASH PAGE"
04/06/2022 8-K Investor presentation
Docs: "Corporate slide presentation of Selecta Biosciences, Inc. dated April 2022"
02/16/2022 8-K Investor presentation
Docs: "2022 PLACEHOLDER FOR SPLASH PAGE"
11/08/2021 8-K Investor presentation
Docs: "Slide Presentation of Selecta Biosciences, Inc."
09/30/2020 8-K Quarterly results
06/18/2020 8-K Investor presentation
Docs: "SEL-212 SEL-212 SEL-212 SEL-212 SEL-212 100"
01/13/2020 8-K Investor presentation
Docs: "SEL-212 SEL-212 SEL-212 SEL-212 SEL-212 100"
11/19/2019 8-K Quarterly results
09/30/2019 8-K Quarterly results
01/07/2019 8-K Investor presentation
Docs: "of The Private Securities Litigation Reform Act of 1995. Actual"
08/09/2018 8-K Investor presentation
Docs: "Canaccord Genuity Presentation Nasdaq: SELB August 2018"
06/04/2018 8-K Investor presentation
Docs: "Jefferies Presentation Nasdaq: SELB June 2018"
03/27/2018 8-K Investor presentation
Docs: "of The Private Securities Litigation Reform Act of 1995. Actual"
01/08/2018 8-K Investor presentation
Docs: "of The Private Securities Litigation Reform Act of 1995. Actual"
11/14/2017 8-K Investor presentation
11/07/2017 8-K Investor presentation, Quarterly results
Docs: "Selecta Biosciences Announces Third Quarter 2017 Financial Results and Provides Corporate Update",
"Third Quarter 2017 Conference"
06/15/2017 8-K Form 8-K - Current report
05/11/2017 8-K Investor presentation, Quarterly results
Docs: "Selecta Biosciences Announces First Quarter 2017 Financial Results and Provides Corporate Update",
"SEL-212 Designed to Treat Severe Gout Patients,"
03/27/2017 8-K Form 8-K - Current report
01/09/2017 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy